Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 7/20 | 0.92 |
| ▸ | P2RY2 | P41231 | 4/20 | 0.92 |
| ▸ | P2RX1 | P51575 | 4/20 | 0.92 |
| ▸ | P2RX3 | P56373 | 4/20 | 0.92 |
| ▸ | SRC | P12931 | 2/20 | 0.92 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.92 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.92 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.92 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.92 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.86 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.86 |
| ▸ | MACROD2 | A1Z1Q3 | 1/20 | 0.86 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.86 |
| ▸ | MACROD1 | Q9BQ69 | 1/20 | 0.86 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.85 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.85 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.85 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.85 |
| ▸ | LDHA | P00338 | 1/20 | 0.85 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine Diphosphate SCHEMBL29979301 | 1.00 | P2RY1 (0.92) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Diphosphate SCHEMBL14613190 | 1.00 | P2RY1 (0.92) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Diphosphate SCHEMBL29358868 | 1.00 | P2RY1 (0.92) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Diphosphate SCHEMBL24103 | 1.00 | P2RY1 (0.92) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Diphosphate SCHEMBL18089780 | 1.00 | P2RY1 (0.92) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Diphosphate SCHEMBL18785159 | 1.00 | P2RY1 (0.92) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Diphosphate SCHEMBL12789537 | 1.00 | P2RY1 (0.92) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Diphosphate SCHEMBL14180716 | 1.00 | P2RY1 (0.92) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Diphosphate SCHEMBL195251 | 1.00 | P2RY1 (0.92) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Diphosphate SCHEMBL29397735 | 1.00 | P2RY1 (0.92) | P2RY1P2RY2P2RX1P2RX3SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 749 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612624-B2 | Light-inducible CRISPR/Cas9 system for genome editing | THE JOHNS HOPKINS UNIVERSITY (US) | 2026-04-28 | — | — | US | claimed |
| CN-111755744-B | Rapid lithium ion transmission material, and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2024-03-12 | — | — | CN | claimed |
| US-20230399376-A1 | BINDING PROTEINS COMPRISING THE EXTRACELLULAR DOMAIN OF CD39 AND METHODS OF TREATING OR PREVENTING NEUROLOGICAL DISEASES | BAKER HEART AND DIABETES INST (AU) | 2023-12-14 | — | — | US | claimed |
| CN-116735850-A | Convenient platelet function testing device, kit and method thereof | 美高怡生生物电子科技(北京)有限公司 | 2023-09-12 | — | — | CN | claimed |
| US-20220403378-A1 | LIGHT-INDUCIBLE CRISPR/CAS9 SYSTEM FOR GENOME EDITING | THE JOHNS HOPKINS UNIVERSITY | 2022-12-22 | — | — | US | claimed |
| CN-113655227-A | Multi-connected detection kit for screening neonatal diseases, and preparation method and use method thereof | 广州俊通生物科技有限公司 | 2021-11-16 | — | — | CN | claimed |
| US-11160866-B2 | Biomaterials for delivery of blood extracts and methods of using same | MOSAIC BIOSCIENCES, INC. (US) | 2021-11-02 | — | — | US | claimed |
| CN-111635532-B | Aggregation-induced fluorescence guest functionalized composite infinite coordination polymer nanoparticle and preparation and application thereof | 华东师范大学 | 2021-07-27 | — | — | CN | claimed |
| WO-2021081469-A2 | LIGHT-INDUCIBLE CRISPR/CAS9 SYSTEM FOR GENOME EDITING | THE JOHNS HOPKINS UNIVERSITY (US) | 2021-04-29 | — | — | WO | claimed |
| CN-111755744-A | Rapid lithium ion transmission material and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2020-10-09 | — | — | CN | claimed |
| EP-0202094-A2 | Process for producing physiologically active substance | UNITIKA LTD. (JP) | 1986-11-20 | — | — | EP | claimed |
| EP-0200541-A2 | Immunochemical method and analytical composition and element for determination of creatine kinase-MB | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1986-11-05 | — | — | EP | claimed |
| US-4577012-A | ABSORPTION ON ACTIVATED CARBON, ELUTION WITH ALKALI HYDROXIDE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1986-03-18 | — | — | US | claimed |
| EP-0071087-B1 | IMPROVED DETERMINATION OF CREATINE PHOSPHOKINASE IN BODY FLUIDS | SERAGEN DIAGNOSTICS, INC. (US) | 1985-04-24 | — | — | EP | claimed |
| US-4473496-A | Intramolecularly crosslinked hemoglobin | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1984-09-25 | — | — | US | claimed |
| EP-0071087-A1 | Improved determination of creatine phosphokinase in body fluids | SERAGEN DIAGNOSTICS, INC. (US) | 1983-02-09 | — | — | EP | claimed |
| US-4277562-A | Stabilized liquid enzyme and coenzyme compositions | MEDICAL ANALYSIS SYSTEMS, INC. | 1981-07-07 | — | — | US | claimed |
| US-4271264-A | Stabilized liquid enzyme and coenzyme compositions | MEDICAL ANALYSIS SYSTEMS, INC. | 1981-06-02 | — | — | US | claimed |
| US-4250254-A | USING AN AQUEOUS VEHICLE, A MISCIBLE POLYOL SOLVENT, AND A POLYMER; PH; SHELF LIFE; MEDICAL DIAGNOSIS | MEDICAL ANALYSIS SYSTEMS, INC. | 1981-02-10 | — | — | US | claimed |
| US-4012286-A | CLINICAL COLORIMETERS | THE DOW CHEMICAL COMPANY (US) | 1977-03-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11160866-B2 | Biomaterials for delivery of blood extracts and methods of using same | PDGFA, PGF, MATR3 | P2RY1 3042/4885P2RY2 3128/4885P2RX1 3537/4885 |
| US-12612624-B2 | Light-inducible CRISPR/Cas9 system for genome editing | RNMT, AMPD2, NT5C2 | P2RY1 1518/4885P2RY2 798/4885P2RX1 1724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.